April Polite
Gerontology · Waxahachie, TXNPI 1508565649
Payments from drug & device makers
Across 118 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$335
- Eisai Inc.$285
- Novartis$250
- Lundbeck LLC$180
- Biogen$176
- UCB, Inc.$169
- plus $918 from 19 others
What the payments were for
- Food & beverage$2,313100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $335 |
| Eisai Inc. | 12 | $285 |
| Novartis | 11 | $250 |
| Lundbeck LLC | 10 | $180 |
| Biogen | 9 | $176 |
| UCB, Inc. | 7 | $169 |
| Amneal Pharmaceuticals LLC | 9 | $162 |
| Lilly USA, LLC | 7 | $121 |
| Vanda Pharmaceuticals Inc. | 4 | $92 |
| Impel Pharmaceuticals Inc. | 3 | $57 |
| Bristol Myers Squibb | 3 | $55 |
| Pfizer | 3 | $54 |
| SK Life Science, Inc. | 2 | $53 |
| GE HealthCare | 3 | $50 |
| AstraZeneca | 2 | $43 |
| EMD Serono, Inc. | 1 | $41 |
| Tanabe Pharma America, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Amgen | 1 | $20 |
| NS Pharma, Inc. | 1 | $20 |
| Biotronik NRO, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Medtronic | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
How this compares
$2,313 in reported general payments places this provider in the 80th percentile of 653 gerontology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 339 | $9,331 |
| Dalfampridine ErDalfampridine | 11 | $8,307 |
| Duloxetine Hcl | 106 | $2,833 |
| Donepezil Hcl | 142 | $1,999 |
| Primidone | 74 | $1,947 |
| Gabapentin | 107 | $1,596 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 65 | $1,561 |
| Levetiracetam | 50 | $1,517 |
| Lacosamide | 23 | $1,075 |
| Propranolol Hcl ErPropranolol Hcl | 14 | $1,031 |
| Baclofen | 24 | $623 |
| Lamotrigine | 24 | $585 |
| Carbamazepine | 19 | $503 |
| Pregabalin | 44 | $489 |
| Amitriptyline Hcl | 22 | $409 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Waxahachie
- Kimberly WelchCoppell$113K
- Tiffany KesslerDallas$84K
- Jennifer WestFort Worth$67K
- Meagan ChavarriaHouston$40K
- Bailey EstesAbilene$34K
- Scott ZelaHouston$28K
- Marissa Marti-SmithDallas$27K
- Andrew BargerAustin$22K
- Samantha BoggsGalveston$15K
- Amber ArmstrongAustin$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.